Blog

Yüksel Ürün: An honor and joy to be featured in The ASCO Post

Photo taken from Yüksel Ürün/X

Dec 1, 2024, 15:25

Yüksel Ürün: An honor and joy to be featured in The ASCO Post

Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X:

“It is truly an honor and joy to be featured in The ASCO Post!

Reflecting on the power of social media in oncology, the significance of global collaboration, and the invaluable lessons I gained during my time at Dana-Farber Cancer Institute has been deeply meaningful.

The American Society of Clinical Oncology (ASCO) Leadership Development Program taught me that leadership is more than a title—it’s a commitment shaped by advocacy, integrity, and collaboration.

These experiences remind me of the shared mission that unites us all: building a better future for our patients.

I am sincerely grateful to everyone who has supported me on this journey.
Together, we can continue to make a meaningful difference in the lives of so many.”

Neeraj Agarwal, Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, shared this post, adding:

“Congrats, Yuksel, on everything you have achieved through your hard work and passion. We look forward to your incredible career trajectory in the years to come. Thanks for sharing your story!”

Silke Gillessen, Medical and Scientific Director of the Oncology Institute of Southern Switzerland, also congratulated Yuksel:

“Compliments, Yüksel, also from my side, you and your work are so impressive. Looking forward to hear more from you and your amazing team!”

Yüksel Ürün

More posts featuring Yüksel Ürün.

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.

Neeraj Agarwal is a Professor of Medicine, and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), University of Utah. He also directs the Genitourinary Oncology (GU) Program, and the Center of Investigational Therapeutics (CIT) at the HCI.

Dr. Agarwal is an Advisor to the Oncology Drug Advisory Committee and the United States Food and Drug Administration, leads early therapeutics in the SWOG genitourinary cancers committee, and is the Chief Editor of ASCO Daily News.

Silke Gillessen is the Medical and Scientific Director of the Oncology Institute of Southern Switzerland and a Full Professor at University of Italian Switzerland. Her expertise focuses on genitourinary (GU) cancers.